Alternative mechanisms of action of anti-oestrogens Anthony A. CollettaJohn R. BensonMichael Baum OriginalPaper Pages: 5 - 9
Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats Yvonne P. DraganSusan FaheyHenry C. Pitot OriginalPaper Pages: 11 - 25
What do we know and what don't we know about tamoxifen in the human uterus Andreas FriedlV. Craig Jordan OriginalPaper Pages: 27 - 39
Molecular mechanisms of antiestrogen action in breast cancer V. Craig Jordan OriginalPaper Pages: 41 - 52
Identification and management of the woman at increased risk for breast cancer development Monica Morrow OriginalPaper Pages: 53 - 60
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial T. J. PowlesA. L. JonesJ. B. Davey OriginalPaper Pages: 73 - 82
Droloxifene, a new antiestrogen: Its role in metastatic breast cancer Winrich RauschningKathleen I. Pritchard OriginalPaper Pages: 83 - 94
Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells Colin K. W. WattsKimberley J. E. SweeneyRobert L. Sutherland OriginalPaper Pages: 95 - 105
Regulation of insulin-like growth factors by antiestrogen Robert WinstonPai C. KaoDavid T. Kiang OriginalPaper Pages: 107 - 115
Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice Douglas M. WolfV. Craig Jordan OriginalPaper Pages: 117 - 127
The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain Douglas M. WolfV. Craig Jordan OriginalPaper Pages: 129 - 138
